Skip to Main Content
Mental Health & Behavioral Research

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

What is the purpose of this trial?

This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.

  • Trial with
    Yale University School of Medicine, YCCI Pilot Project Grant, and National Institute of Mental Health (NIMH)
  • Ages
    21 years - 55 years
  • Gender

Contact Information

For more information about this study, including how to volunteer, contact Study Team

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC